Covidien Announces European Launch of Pipeline™ Flex Embolization Device

DUBLIN, Ireland--(BUSINESS WIRE)--Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.

Help employers find you! Check out all the jobs and post your resume.